Dr. Reddy’s, Promius Pharma file NDA with FDA for migraine candidate

This article was originally published here

Dr. Reddy’s Laboratories and its subsidiary Promius Pharma have filed a new drug application (NDA) with the US Food and Drug Administration (USFDA) for migraine candidate DFN-02.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply